Introduction
Acinetobacter baumannii (A. baumannii) is a serious opportunistic and multidrug-resistant (MDR) pathogen that is responsible for nosocomial infections and frequently causes bacteremia and ventilator-related pneumonia in intensive care units (ICU) and health facilities [1, 2] . A. baumannii is a coccobacillus gram-negative bacterium, aerobic and nonfermented that belongs to the Moraxellaceae family. These species have a high prevalence in both community and hospital, especially among patients in ICU as well as high risk patients [3] . A. baumannii can be isolated from numerous sources such as soil, water, animals, and humans [4, 5] . Moreover, it has been implicated in different nosocomial infections, including endocarditis, meningitis, wounds, blood and infections of the skin, soft tissues, urinary tract, and those originating from other hospital environments [6] .
The treatment of A. baumannii is difficult as it can be resistant to multiple classes of antimicrobials [7] . A. baumannii is naturally resistant to some antibiotics such as cephalosporin's. However, it has a great capacity to develop resistance against many antibiotics, including carbapenems, aminoglycosides, and fluoroquinolones [8] . The resistance is acquired through the transfer of mobile genetic elements like Integrons, plasmids or transposons which carry groups of genes encoding resistance to various antibiotic families [9] . A. baumannii can produce carbapenemases, as the principle mechanism is of responsiblity for carbapenem resistance. This resistance is dramatically 
Materials and Methods

Bacterial isolates
The primary culture showed polymicrobial growth in 65.2% of the detected samples. 
Statistical Analysis
The data were analyzed by Chi-square, Table 2 .
The result of M-PCR in A.baumannii
Molecular typing of genes related to
A. baumannii antibiotic resistance pattern shows the frequency of genes (Fig. 3) A. baumannii isolates detected from different burnt patients showed that the most frequent age range of the patients were between 61-70 (60.2%) who were hospitalized in different wards of the hospitals. Also 59% of patients were women in this study. and aminoglycoside compounds in a range between 9.9-31.4% [24] . [29] .
Conclusion
The results of this cross-sectional study were in agreement with similar studies around the world. Due to increased drug resistance, wider 
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